Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Andersson

Showing results (31-40 of 60) with videos related to

Pageof 6
Sort By:
Scientific Reports|December 18, 2020
High yield cyclotron production of a novel <sup>133/135</sup>La theranostic pair for nuclear medicineBryce J B Nelson, John Wilson, Jan D Andersson, et al.
Pharmaceuticals (Basel, Switzerland)|November 25, 2023
Theranostic Imaging Surrogates for Targeted Alpha Therapy: Progress in Production, Purification, and ApplicationsBryce J B Nelson, John Wilson, Jan D Andersson, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|July 1, 1992
Papaverine effects on PGI2 and TXA2 release from the canine vascular wallJ S Brunkwall, J C Stanley, T Jackson, et al.
Clinical Physiology (Oxford, England)|July 1, 1990
Gamma 2-MSH increases during graded exercise in healthy subjects: comparison with plasma catecholamines, neuropeptides, aldosterone and renin activityS Valdemarsson, D Andersson, A Bengtsson, et al.
European Journal of Clinical Chemistry and Clinical Biochemistry : Journal of the Forum of European Clinical Chemistry Societies|June 1, 1997
Effects of administration of antioxidants in acute intermittent porphyriaS Thunell, D Andersson, P Harper, et al.
Lakartidningen|June 29, 1994
[When the security requirements are fulfilled. Early discharge as an alternative to care at maternity wards]B Winbladh, D Andersson, P Carlsson, et al.
Acta Paediatrica (Oslo, Norway : 1992)|June 17, 1998
Recurrent Pseudomonas bronchopneumonia and other symptoms as in cystic fibrosis in a child with type I pseudohypoaldosteronismL Marthinsen, R Kornfält, M Aili, et al.
Lakartidningen|May 12, 1982
[Advantages to patients having dialysis at county hospitals]R Henning, O Hoheisel, K Lilbaeck, et al.
Neuroscience Letters|August 31, 1992
A novel inositol phosphate selectively inhibits vasoconstriction evoked by the sympathetic co-transmitters neuropeptide Y (NPY) and adenosine triphosphate (ATP)C Wahlestedt, D J Reis, H Yoo, et al.
International Journal of Clinical Practice|September 24, 2005
Cost-effectiveness of acarbose for the management of impaired glucose tolerance in SwedenS Quilici, J Chancellor, G Maclaine, et al.
Pageof 6

Showing results (31-40 of 60) with videos related to

Sort By:
Pageof 6
Scientific Reports|December 18, 2020
High yield cyclotron production of a novel <sup>133/135</sup>La theranostic pair for nuclear medicineBryce J B Nelson, John Wilson, Jan D Andersson, et al.
Pharmaceuticals (Basel, Switzerland)|November 25, 2023
Theranostic Imaging Surrogates for Targeted Alpha Therapy: Progress in Production, Purification, and ApplicationsBryce J B Nelson, John Wilson, Jan D Andersson, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|July 1, 1992
Papaverine effects on PGI2 and TXA2 release from the canine vascular wallJ S Brunkwall, J C Stanley, T Jackson, et al.
Clinical Physiology (Oxford, England)|July 1, 1990
Gamma 2-MSH increases during graded exercise in healthy subjects: comparison with plasma catecholamines, neuropeptides, aldosterone and renin activityS Valdemarsson, D Andersson, A Bengtsson, et al.
European Journal of Clinical Chemistry and Clinical Biochemistry : Journal of the Forum of European Clinical Chemistry Societies|June 1, 1997
Effects of administration of antioxidants in acute intermittent porphyriaS Thunell, D Andersson, P Harper, et al.
Lakartidningen|June 29, 1994
[When the security requirements are fulfilled. Early discharge as an alternative to care at maternity wards]B Winbladh, D Andersson, P Carlsson, et al.
Acta Paediatrica (Oslo, Norway : 1992)|June 17, 1998
Recurrent Pseudomonas bronchopneumonia and other symptoms as in cystic fibrosis in a child with type I pseudohypoaldosteronismL Marthinsen, R Kornfält, M Aili, et al.
Lakartidningen|May 12, 1982
[Advantages to patients having dialysis at county hospitals]R Henning, O Hoheisel, K Lilbaeck, et al.
Neuroscience Letters|August 31, 1992
A novel inositol phosphate selectively inhibits vasoconstriction evoked by the sympathetic co-transmitters neuropeptide Y (NPY) and adenosine triphosphate (ATP)C Wahlestedt, D J Reis, H Yoo, et al.
International Journal of Clinical Practice|September 24, 2005
Cost-effectiveness of acarbose for the management of impaired glucose tolerance in SwedenS Quilici, J Chancellor, G Maclaine, et al.
Pageof 6